Aligos Therapeutics Inc.
About Aligos Therapeutics Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Private Placement T: - FT: Private Placement |
A: 105000000 MR: - FA: $105 million FAN: 105000000 |
D: 2025-02-12 FD: 2025-02-12 |
2 investors |
| 2 |
RT: Private Placement T: - FT: Private Placement |
A: 92000000 MR: - FA: $92 million FAN: 92000000 |
D: 2023-10-23 FD: 2023-10-23 |
5 investors |
Growth Metrics
Team & Leadership
Lawrence M. Blatt
Chairman, President, & Chief Executive Officer
Julian A. Symons
Executive Vice President, Chief Scientific Officer
Lesley Ann Calhoun
Executive Vice President, Chief Operating Officer, and Chief Financial Officer
Hardean Achneck
Executive Vice President, Chief Medical Officer
Sushmita M. Chanda
Executive Vice President, Chief Development Officer
David B. Smith
Executive Vice President, Head of Chemical Operations
Recent News
Aligos Therapeutics Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- aligos.com
- Industries
- Biopharmaceuticals / Healthcare
- Company Size
- ~300 employees (est.)
- Locations
-
SOUTH SAN FRANCISCO, Calif.
South San Francisco, California
South San Francisco, Calif.
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro